Welcome to our dedicated page for Ionq SEC filings (Ticker: IONQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Quantum computing promises transformative returns, yet IonQ’s SEC documents can read like a physics dissertation. Locating R&D burn rates, deciphering option grants, or spotting dilution warnings inside a single IonQ annual report 10-K simplified often takes hours. Stock Titan eliminates that pain. Our AI delivers IonQ SEC filings explained simply, showing the numbers and milestones without the math PhD.
Every time IonQ hits the EDGAR tape, we post the filing within seconds and pair it with machine-written context. Need the next IonQ quarterly earnings report 10-Q filing or an IonQ 8-K material events explained? It’s already summarized. Want alerts the moment a director sells shares? Our feed of IonQ Form 4 insider transactions real-time keeps you ahead. Below you’ll find:
- 10-K & 10-Q breakdowns highlighting cash runway, government contract backlog, and qubit roadmaps.
- Form 4 dashboards for IonQ insider trading Form 4 transactions and IonQ executive stock transactions Form 4.
- Proxy statement insights detailing IonQ proxy statement executive compensation.
- Instant notes on 8-K releases, mergers, or financing updates.
Use these AI summaries to compare quarter-over-quarter progress, monitor insider sentiment, or share concise takeaways with clients. Whether you’re modeling cash needs or validating strategic milestones, understanding IonQ SEC documents with AI turns dense disclosures into actionable clarity. Save time, catch details others miss, and rely on our IonQ earnings report filing analysis to stay informed about the company pushing quantum boundaries.
IonQ director William F. Scannell received a grant of 5,513 restricted stock units (RSUs) on June 18, 2025. Following this transaction, Scannell now beneficially owns 140,560 shares directly.
Key details of the RSU grant:
- The RSUs were granted at $0 exercise price
- Vesting occurs at the earlier of: - The 2026 Annual Meeting date (or day prior if service ends at meeting) - June 18, 2026
- Vesting is contingent on continued service as Board member
This Form 4 filing represents standard equity compensation for board service, aligning the director's interests with shareholders through equity ownership. The transaction was executed under normal circumstances with no indication of unusual trading patterns.
IonQ director Gabrielle B. Toledano received a grant of 5,513 restricted stock units (RSUs) on June 18, 2025. Following this transaction, Toledano's direct ownership increased to 6,305 shares.
Key terms of the RSU award:
- Grant was made at $0 exercise price
- RSUs will vest in full at the earlier of:
- 2026 Annual Meeting (or day before if service ends at meeting)
- June 18, 2026
- Vesting is contingent on continued service as Board member
This Form 4 filing represents standard equity compensation for non-employee directors, aligning the director's interests with shareholders through stock ownership.
IonQ director Inder M. Singh received a grant of 5,513 restricted stock units (RSUs) on June 18, 2025. Following this transaction, Singh now beneficially owns a total of 32,603 shares directly.
Key terms of the RSU award:
- Vesting occurs at the earlier of: - The 2026 Annual Meeting date (or day prior if service ends at meeting) - June 18, 2026
- Vesting is contingent on continued service as Board member
- The RSUs were granted at $0 exercise price
This Form 4 filing represents standard equity compensation for board service, aimed at aligning the director's interests with shareholders. The transaction was executed under normal circumstances with no indication of unusual trading patterns.
IonQ director Kathryn K. Chou received a grant of 5,513 restricted stock units (RSUs) on June 18, 2025. Following this transaction, Chou beneficially owns a total of 67,628 shares directly.
Key terms of the RSU award:
- Vesting occurs at the earlier of: - 2026 Annual Meeting (or day prior if service ends at meeting) - June 18, 2026
- Vesting is contingent on continued service as Board member
- RSUs were granted at $0 exercise price
This Form 4 filing represents a standard director equity compensation grant, likely part of IonQ's annual board member compensation package. The transaction was executed under normal circumstances with no indication of any Rule 10b5-1 trading plan involvement.
IonQ Director Robert T. Cardillo received a grant of 5,513 restricted stock units (RSUs) on June 18, 2025. Following this transaction, Cardillo's direct ownership increased to 37,436 shares.
Key details of the RSU award:
- The RSUs were granted at $0 exercise price
- Vesting occurs at the earlier of: - The 2026 Annual Meeting date (or day prior if service ends at meeting) - June 18, 2026
- Vesting is contingent on continued service as Board member
This Form 4 filing, executed by Attorney-in-Fact Stacey Giamalis, represents standard equity compensation for non-employee directors, aligning the director's interests with shareholders through equity ownership.
IonQ Chief Financial Officer Thomas G. Kramer has executed a significant stock transaction on June 16, 2025, selling 216,000 shares of common stock at a weighted average price of $38.1131 per share. The transaction was conducted through a pre-established Rule 10b5-1 trading plan adopted on March 14, 2025.
Following the transaction, Kramer retains direct ownership of 718,516 shares and indirect ownership of 5 shares through his child. The sales were executed at prices ranging from $36.07 to $39.14 per share.
Key transaction details:
- Transaction was executed pursuant to a Rule 10b5-1 plan, indicating pre-planned, scheduled trading activity
- Total transaction value approximately $8.23 million
- Significant retained ownership position indicates continued alignment with shareholder interests
- Filing was signed by attorney-in-fact Stacey Giamalis on June 18, 2025
IonQ Executive Chair Peter Chapman reported significant insider transactions executed through a pre-planned Rule 10b5-1 trading plan established on March 14, 2025. The transactions occurred over two consecutive days:
- On June 16, 2025: Exercised 3,581,193 stock options at $0.1334 per share and subsequently sold them at an average price of $38.126
- On June 17, 2025: Exercised 910,740 stock options at $0.1334 per share and sold them at an average price of $37.7787
Following these transactions, Chapman retains 390,329 shares of common stock held directly and 1,604,972 vested stock options exercisable until May 16, 2029. The substantial price difference between the exercise price ($0.1334) and sale prices (>$36) resulted in significant gains. These pre-planned sales may indicate portfolio diversification rather than a lack of confidence in the company.
FAQ
What is the current stock price of Ionq (IONQ)?
What is the market cap of Ionq (IONQ)?
